A tailored Care Home Clinical Assessment Tool (CHCAT) for front line clinicians

为一线临床医生量身定制的疗养院临床评估工具 (CHCAT)

• 批准号: 10083496
• 金额: $ 31.87万
• 依托单位: DEM DX LIMITED
• 依托单位国家: 英国
• 项目类别: Collaborative R&D
• 财政年份: 2023
• 资助国家: 英国
• 起止时间: 2023 至 无数据
• 项目状态: 未结题
• 来源: https://gtr.ukri.org/projects?ref=10083496
• 关键词: tailored; Care; Home; Clinical; Assessment

DemDx will deliver an urgently needed Care Home focused Clinical Assessment Tool (CHCAT).The need is driven by the introduction of the Enhanced Health in Care Homes initiative-aimed at providing a more proactive health service to the elderly and frail care home residents by increasing frontline clinical support to care home nursing staff, community rapid response teams led primarily by Allied Healthcare Professionals (AHPs).Care home nursing staff and communities teams require expanded generalist knowledge across hundreds of conditions, signs, symptoms and "red flags," recognition of patient-specific comorbidities, and awareness of frequently updated gold standard protocols. These clinicians are urgently calling for tools to support them in their expanded roles.Currently both community and care home clinical teams rely heavily on clinical guidance from GP surgeries (with knock on impact on GP workloads and waiting lists) or over-refer patients to A&E, putting further pressure on acute care pathways including ambulance call outs..CHCAT builds upon DemDx's sector-leading clinical reasoning intelligent support platform (CRISP), co-developed via InnovateUK and NIHR-funded engagement in five NHS Trusts. It is the gold standard in support tools for allied health professionals.CHCAT will be a revolutionary cloud-based clinical assessment tool, using AI and data to support community/care home staff in better, safer, quicker clinical assessment and treatment or referral decisions.Innovations include:* AI allowing dynamic consideration of complex patterns and associations across 10,000s of symptoms, comorbidities and "red flags" in validated NICE data.* A data-driven structure enabling AHPs to make sense of complex data associations to make safe, consistent decisions, with patient-centric data weighting enabling prioritisation of most probable conditions, to inform best referral options* Powered by a 12m-patient CPRD dataset.* Outputs are tailored to ageing-specific clinical assessment pathways for the 5+ most common ailments* CHCAT is fully interoperable, seamlessly integrated into patient primary care/acute pathways.

DEMDX将提供急需护理室的临床评估工具（CHCAT）。需求是由提出的养老院中增强的健康倡议驱动的，该倡议是为了为老年人和脆弱的护理院居民提供更积极的健康服务，以增加护理人员护理人员的临床临床支持团队，社区快速响应团队由所有人的保健组和全体保健服务公司（AHPS）促进了临床支持，并促进了整个临床支持。在数百个条件，体征，症状和“危险信号”，对患者特异性合并症的识别以及经常更新的黄金标准方案的认识中，扩大了通才知识。这些临床医生紧急呼吁使用工具来支持他们的角色。目前，社区和养老院的临床团队都在很大程度上依赖于GP手术的临床指导（对GP的工作负载和等待列表的影响震撼）或向A＆E推荐了A＆E的临床，以在包括Amcute Careways的急诊式竞争中，包括Ambulance Sultection。 （Crisp），通过Innovateuk和NIHR资助的五个NHS Trusts共同开发。它是盟军卫生专业人员支持工具的黄金标准。奇卡特将是一种基于革命性的基于云的临床评估工具，使用AI和数据支持社区/护理人员的员工，以更好，更安全，更快，更快，更快的临床评估和治疗或推荐决定或转介决定。使AHP能够理解复杂的数据关联，以做出安全，一致的决策，并以患者为中心的数据加权能够优先考虑最可能的条件，以告知最佳推荐选项*由12mpatient CPRD数据集提供的功能。途径。